Aurobindo Pharma stock growth reflects a strong 16.3% increase in Q1, showcasing the company's market resilience and potential.
Read MoreAurobindo Pharma stock growth reflects a strong 16.3% increase in Q1, showcasing the company's market resilience and potential.
Read More
Aurobindo Pharma inhaler approval brings a proven safe solution for asthma patients seeking effective treatment options.
Read More